Related Experiment Video
Updated: Jan 26, 2026

The Galleria mellonella Waxworm Infection Model for Disseminated Candidiasis
Published on: November 17, 2018
Persistent hematogenous dissemination in pulmonary P. jiroveci infection
E Righi1,2, A La Rosa3, A Sartor4
1Infectious Diseases Division, Santa Maria della Misericordia University Hospital, Udine, Italy. elda.righi@libero.it.
Abstract:
Pneumocystis jiroveci pneumonia in non-HIV patients is infrequent and characterized by atypical presentations and increased severity. Although hematogenous dissemination from the lungs can lead to extrapulmonary infections, isolation of oocysts from blood in human subjects has not been documented. We report a case of P. jiroveci pneumonia with persistent isolation of oocysts from blood and positivity of P. jiroveci polymerase chain reaction. The patient presented with bilateral diffuse pulmonary nodules and received prolonged treatment with trimethoprim/sulfamethoxazole.
Insights
Pneumocystis jiroveci pneumonia is rare in non-HIV patients. This study documents the first isolation of Pneumocystis jiroveci oocysts from blood in a human patient, suggesting potential hematogenous spread.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Pulmonology
Background:
- Pneumocystis jiroveci pneumonia (PCP) is uncommon in non-HIV individuals.
- PCP in this population often presents atypically and with greater severity.
- Extrapulmonary PCP can occur via hematogenous dissemination, but oocysts in blood are undocumented.
Observation:
- A non-HIV patient presented with bilateral diffuse pulmonary nodules.
- The patient showed persistent isolation of Pneumocystis jiroveci oocysts in blood samples.
- P. jiroveci DNA was consistently detected via polymerase chain reaction (PCR).
Findings:
- This case represents the first documented instance of P. jiroveci oocysts isolated from human blood.
- The findings suggest that hematogenous dissemination of P. jiroveci may occur in non-HIV patients.
- Prolonged trimethoprim/sulfamethoxazole treatment was administered.
Implications:
- This discovery expands the understanding of P. jiroveci dissemination routes.
- It highlights the importance of considering extrapulmonary P. jiroveci in non-HIV patients.
- Further research is needed to clarify the clinical significance and diagnostic approaches for disseminated PCP.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Other Pulmonary Disorders
Factors Affecting Pulmonary Ventilation
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

